Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention

American Journal of Cardiology

Volumn 95, Issue 4, 2005, Pages 502-505

  Patti, Giuseppe ^b   Pasceri, Vincenzo ^b   Carminati, Patrizia ^b   D'Ambrosio, Andrea ^b   Carcagnì, Addolorata ^b   Di Sciascio, Germano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CLOPIDOGREL; DEXAMETHASONE; FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; INFLAMMATION; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 13844299115     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.10.021     Document Type: Article

References (16)

1. G. Patti, A. D'Ambrosio, A. Dobrina, G. Dicuonzo, C. Giansante, N. Fiotti, A. Abbate, G. Guarnirei, G. Di Sciascio Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease J Thromb Thrombolysis 14 2002 139 143
2. G. Patti, A. D'Ambrosio, S. Mega, G. Giorgi, E.M. Zardi, D.M. Zardi, G. Dicuonzo, A. Dobrina, G. Di Sciascio Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction J Am Coll Cardiol 43 2004 35 38
3. G. Patti, G. Di Sciascio, A. D'Ambrosio, G. Dicuonzo, A. Abbate, A. Dobrina Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting Catheter Cardiovasc Interventions 56 2002 341 345
4. G. Patti, G. Di Sciascio, A. D'Ambrosio, G. Dicuonzo, A. Abbate, A. Dobrina Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention Am J Cardiol 89 2002 372 376
5. F. Versaci, A. Gaspardone, F. Tomai, F. Ribichini, P. Russo, I. Proietti, A.S. Ghini, V. Ferrero, L. Chiariello, P.A. Gioffre, F. Romeo, F. Crea Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study) J Am Coll Cardiol 40 2002 1935 1942
6. X. Liu, Y. Huang, C. Hanet, M. Vandormael, V. Legrand, J. Dens, J.L. Vandenbossche, L. Missault, C. Vrints, I. De Scheerder Study of anti-restenosis with the Biodivysio dexamethasone-eluting stent (STRIDE)--a multicenter trial (abstr) Eur Heart J 4 2002 265
7. G. Di Sciascio, M.J. Cowley, E. Goudreau, G.W. Vetrovec, D.E. Johnson Histopathologic correlates of unstable ischemic syndromes in patients undergoing directional coronary atherectomy: in vivo evidence of thrombosis, ulceration, and inflammation Am Heart J 128 1994 419 426
8. J.A. Goldstein, D. Demetriou, C.L. Grines, M. Pica, M. Shoukfeh, W.W. O'Neill Multiple complex coronary plaques in patients with acute myocardial infarction N Engl J Med 343 2000 915 922
9. K. Yasojima, C. Schwab, E.G. McGeer, P.L. McGeer Generation of C-reactive protein and complement components in atherosclerotic plaques Am J Pathol 158 2001 1039 1051
10. C.J. Pepine, J.W. Hirshfeld, R.G. Macdonald, M.A. Henderson, T.A. Bass, S. Goldberg, M.P. Savage, G. Vetrovec, M. Cowley, A.S. Taussig A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty M-HEART Group Circulation 81 1990 1753 1761
11. A. Gaspardone, F. Crea, F. Versaci, F. Tomai, A. Pellegrino, L. Chiariello, P.A. Gioffre Predictive value of C-reactive protein after successful coronary artery stenting in patients with stable angina Am J Cardiol 82 1998 515 518
12. M.C. Morice, P.W. Serruys, J.E. Sousa, J. Fajadet, E. Ban Hayashi, M. Perin, A. Colombo, G. Schuler, P. Barragan, G. Guagliumi, F. Molnar, R. Falotico RAVEL Study Group Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
13. D.J. Kereiakes Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: the role of modulating inflammation Circulation 108 suppl III 2003 III-22 III-27
14. F. Versaci, A. Gaspardone, F. Tomai, F. Crea, L. Chiariello, P.A. Gioffrè Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation Am J Cardiol 85 2000 92 95
15. D.P. Chew, D.L. Bhatt, M.A. Robbins, M.S. Penn, J.P. Schneider, M.S. Lauer, E.J. Topol, S.G. Ellis Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention Circulation 104 2001 992 997
16. A.W. Chan, D.L. Bhatt, D.P. Chew, M.J. Quinn, D.J. Moliterno, E.J. Topol, S.G. Ellis Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention Circulation 105 2002 691 696